Literature DB >> 32901152

Strengthening the sting of immunotherapy.

Sarah Crunkhorn1.   

Abstract

Year:  2020        PMID: 32901152     DOI: 10.1038/s41577-020-00447-1

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic.

Authors:  Chenguang Yu; Vincent F Vartabedian; Ying Jia; H Michael Petrassi; Emily N Chin; Manoj Kumar; Ana M Gamo; William Vernier; Sabrina H Ali; Mildred Kissai; Daniel C Lazar; Nhan Nguyen; Laura E Pereira; Brent Benish; Ashley K Woods; Sean B Joseph; Alan Chu; Kristen A Johnson; Philipp N Sander; Francisco Martínez-Peña; Eric N Hampton; Travis S Young; Dennis W Wolan; Arnab K Chatterjee; Peter G Schultz; John R Teijaro; Luke L Lairson
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

2.  An orally available non-nucleotide STING agonist with antitumor activity.

Authors:  Bo-Sheng Pan; Samanthi A Perera; Jennifer A Piesvaux; Jeremy P Presland; Gottfried K Schroeder; Jared N Cumming; B Wesley Trotter; Michael D Altman; Alexei V Buevich; Brandon Cash; Saso Cemerski; Wonsuk Chang; Yiping Chen; Peter J Dandliker; Guo Feng; Andrew Haidle; Timothy Henderson; James Jewell; Ilona Kariv; Ian Knemeyer; Johnny Kopinja; Brian M Lacey; Jason Laskey; Charles A Lesburg; Rui Liang; Brian J Long; Min Lu; Yanhong Ma; Ellen C Minnihan; Greg O'Donnell; Ryan Otte; Laura Price; Larissa Rakhilina; Berengere Sauvagnat; Sharad Sharma; Sriram Tyagarajan; Hyun Woo; Daniel F Wyss; Serena Xu; David Jonathan Bennett; George H Addona
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.